ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,341Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 86

$801K Total Retail Price of All Prescriptions

Rank: 8 out of 86

320 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

62% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 8,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

60 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,941 769 S3 1 1
LISINOPRIL 761 362 2 3
SIMVASTATIN 750 322 3 2
GABAPENTIN 699 290 4 11
POTASSIUM CHLORIDE 562 259 5 10
RANITIDINE HCL 511 225 6 14
ZOLPIDEM TARTRATE 487 159 7 18
HYDROCHLOROTHIAZIDE 481 264 8 9
FUROSEMIDE 474 282 9 5
METFORMIN HCL 470 200 10 8
NEXIUM 458 291 11 22
AMLODIPINE BESYLATE 397 194 12 4
CYCLOBENZAPRINE HCL 389 74 R 13 56
METOPROLOL TARTRATE 369 157 14 12
OMEPRAZOLE 341 134 15 7
CARVEDILOL 315 186 16 19
LEVOTHYROXINE SODIUM 290 158 17 6
ALLOPURINOL 289 201 18 26
PROAIR HFA 222 70 19 58
PRAVASTATIN SODIUM 209 107 20 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 204 34 21 21
ATORVASTATIN CALCIUM 199 98 22 17
MELOXICAM 175 64 23 20
LANTUS 161 58 24 40
SERTRALINE HCL 160 70 25 31
ATENOLOL 158 86 26 16
CRESTOR 154 88 27 46
INSULIN SYRINGE 152 54 28 49
ENDOCET 145 66 S2 29 137
NOVOLOG 141 49 30 142
ADVAIR DISKUS 132 57 31 62
TAMSULOSIN HCL 131 95 32 34
GLIMEPIRIDE 126 82 33 30
CLOPIDOGREL 121 58 34 37
FLUTICASONE PROPIONATE 117 62 35 36
PLAVIX 113 58 36 53
COMBIVENT 111 62 37 131
TRAMADOL HCL 110 67 38 13
CARISOPRODOL 110 0 R 38 45
CITALOPRAM HBR 104 49 40 23
CLONIDINE HCL 103 71 41 28
TRICOR 102 40 42 89
LIPITOR 98 39 43 93
GLYBURIDE 97 32 R 44 72
CIPROFLOXACIN HCL 92 45 45 59
AZITHROMYCIN 91 27 46 29
TOPIRAMATE 88 0 47 166
OXYCODONE HCL 86 18 S2 48 27
DIGOXIN 82 45 49 69
ZETIA 77 20 50 74
WARFARIN SODIUM 76 41 51 25
AMITRIPTYLINE HCL 76 25 R 51 65
NIFEDIPINE ER 76 57 51 84
LYRICA 75 0 54 75
TRIAMCINOLONE ACETONIDE 74 33 55 109
SPIRONOLACTONE 72 31 56 141
PAROXETINE HCL 71 29 57 63
LACTULOSE 70 60 58 106
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 34 58 80
LOVASTATIN 70 39 58 32
METOLAZONE 69 48 61 152
BENAZEPRIL HCL 67 49 62 66
VENTOLIN HFA 66 25 63 97
OXYCODONE-ACETAMINOPHEN 64 12 S2 64 157
PREDNISONE 64 43 64 50
HYDROXYZINE PAMOATE 64 0 R 64 147
PROMETHAZINE HCL 62 11 R 67 70
TRAZODONE HCL 61 29 68 44
CELEBREX 61 41 68 112
SINGULAIR 61 18 68 83
GLIPIZIDE 59 27 71 43
NORTRIPTYLINE HCL 59 13 71 235
GEMFIBROZIL 59 12 71 169
VENLAFAXINE HCL ER 58 12 74 114
ESCITALOPRAM OXALATE 57 30 75 87
FENTANYL 56 24 S2 76 104
DOXAZOSIN MESYLATE 56 37 76 105
MUPIROCIN 55 34 78 132
HYDROXYZINE HCL 54 0 R 79 186
XOPENEX HFA 54 15 79 201
MECLIZINE HCL 51 29 81 91
CYPROHEPTADINE HCL 50 12 R 82 254
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.